Publication | Open Access

Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy

NanomedicineDrug TargetingNanotherapeuticsDrug-resistant Cancer TherapyEngineeringMedicineExtracellular MicrovesiclesTumor TargetingAnti-cancer AgentBiomedical EngineeringPharmacologyTumor MicroenvironmentTumor Vasculature